Viewing Study NCT00138593


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2026-02-01 @ 3:35 PM
Study NCT ID: NCT00138593
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2005-08-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View
None vildagliptin View